• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制备作为金属β-内酰胺酶抑制剂(MBLI)的碳-14标记的2-(2-巯基乙酰胺基)-3-苯基丙酸,用于与β-内酰胺类抗生素联合给药。

Preparation of Carbon-14 Labeled 2-(2-mercaptoacetamido)-3-phenylpropanoic Acid as Metallo-beta-lactamases Inhibitor (MBLI), for Coadministration with Beta-lactam Antibiotics.

作者信息

Maleki Ali, Taheri-Ledari Reza, Eivazzadeh-Keihan Reza, de la Guardia Miguel, Mokhtarzadeh Ahad

机构信息

Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran.

Department of Analytical Chemistry, University of Valencia, Dr. Moliner 50, 46100, Burjassot, Valencia, Spain.

出版信息

Curr Org Synth. 2019;16(5):765-771. doi: 10.2174/1570179416666190423114704.

DOI:10.2174/1570179416666190423114704
PMID:31984891
Abstract

AIM AND OBJECTIVE

Bacteria could become resistant to β-lactam antibiotics through production of β- lactamase enzymes like metallo-β-lactamase. 2-(2-mercaptoacetamido)-3-phenylpropanoic acid was reported as a model inhibitor for this enzyme. In order to elucidate the mechanism of action in the body's internal environment, preparation of a labeled version of 2-(2-mercaptoacetamido)-3-phenylpropanoic acid finds importance. In this regard, we report a convenient synthetic pathway for preparation of carbon-14 labeled 2-(2- mercaptoacetamido)-3-phenylpropanoic acid.

MATERIALS AND METHODS

This study was initiated by using non-radioactive materials. Then, necessary characterization was performed after each of the reactions. Finally, the synthesis steps were continued to produce the target labeled product. For labeled products, the process was started from benzoic acid-[carboxyl- 14C] which has been prepared from barium 14C-carbonate. Chromatography column and NMR spectroscopy were used for purifications and identification of desired products, respectively. Barium [14C]carbonate was purchased from Amersham Pharmacia Biotech and was converted to [14C]benzyl bromide. Radioactivity was determined using liquid scintillation spectrometer.

RESULTS

We used [14C]PhCH2Br which was previously prepared from [14C]BaCO3, H2SO4, PhMgI, LAH and HBr, respectively. To neutralize the [14C]phenylalanine in acidic condition and to reach an isoelectric point of phenylalanine (pH = 5.48), Pb(OH)2 was used. Next, thioacetic acid and bromo acetic acid were used to prepare (acetylthio) acetic acid. A peptide coupling reagent was used in this stage to facilitating amide bond formation reaction between [14C]methyl-2-amino-3-phenyl propanoate hydrochloride and (acetylthio) acetic acid.

CONCLUSION

Carbon-14 labeled 2-(2-mercaptoacetamido)-3-phenylpropanoic acid via radioactive phenylalanine was obtained with overall chemical yield 73% and radioactivity 65.3 nCi. The labeled target product will be used for in vivo pharmacological studies.

摘要

目的

细菌可通过产生金属β-内酰胺酶等β-内酰胺酶对β-内酰胺类抗生素产生耐药性。2-(2-巯基乙酰氨基)-3-苯基丙酸被报道为该酶的一种模型抑制剂。为阐明其在体内环境中的作用机制,制备2-(2-巯基乙酰氨基)-3-苯基丙酸的标记版本具有重要意义。在这方面,我们报道了一种制备碳-14标记的2-(2-巯基乙酰氨基)-3-苯基丙酸的简便合成途径。

材料与方法

本研究首先使用非放射性材料开始。然后,在每个反应后进行必要的表征。最后,继续合成步骤以生产目标标记产物。对于标记产物,该过程从由碳酸钡-14C制备的苯甲酸-[羧基-14C]开始。分别使用色谱柱和核磁共振光谱对所需产物进行纯化和鉴定。碳酸钡-14C购自安玛西亚 Pharmacia Biotech,并转化为苄基溴-14C。使用液体闪烁光谱仪测定放射性。

结果

我们使用了先前分别由碳酸钡-14C、硫酸、苯基溴化镁、氢化铝锂和氢溴酸制备的苄基溴-14C。为在酸性条件下中和苯丙氨酸-14C并达到苯丙氨酸的等电点(pH = 5.48),使用了氢氧化铅。接下来,使用硫代乙酸和溴乙酸制备(乙酰硫基)乙酸。在该阶段使用肽偶联试剂以促进盐酸-14C-甲基-二氨基-3-苯基丙酸酯与(乙酰硫基)乙酸之间的酰胺键形成反应。

结论

通过放射性苯丙氨酸获得了碳-14标记的2-(2-巯基乙酰氨基)-3-苯基丙酸,总化学产率为73%,放射性为65.3 nCi。该标记的目标产物将用于体内药理学研究。

相似文献

1
Preparation of Carbon-14 Labeled 2-(2-mercaptoacetamido)-3-phenylpropanoic Acid as Metallo-beta-lactamases Inhibitor (MBLI), for Coadministration with Beta-lactam Antibiotics.制备作为金属β-内酰胺酶抑制剂(MBLI)的碳-14标记的2-(2-巯基乙酰胺基)-3-苯基丙酸,用于与β-内酰胺类抗生素联合给药。
Curr Org Synth. 2019;16(5):765-771. doi: 10.2174/1570179416666190423114704.
2
Synthesis of (2-mercaptoacetyl)-L-[2- C]tryptophan as a selective metallo-β-lactamase inhibitor via [2- C]indole based on chiral pool strategy.基于手性源策略,通过[2-¹³C]吲哚合成(2-巯基乙酰基)-L-[2-¹³C]色氨酸作为选择性金属β-内酰胺酶抑制剂。
J Labelled Comp Radiopharm. 2017 Feb;60(2):130-134. doi: 10.1002/jlcr.3485. Epub 2017 Jan 25.
3
Challenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-β-Lactamases.基于硫醇的金属β-内酰胺酶广谱抑制剂开发中的挑战
ACS Infect Dis. 2018 Mar 9;4(3):360-372. doi: 10.1021/acsinfecdis.7b00129. Epub 2017 Dec 12.
4
Crystallization-induced chiral inversion as the key step for synthesis of (S)-2-acetylthio-3-phenylpropanoic acid from l-phenylalanine.结晶诱导的手性反转作为从L-苯丙氨酸合成(S)-2-乙酰硫基-3-苯基丙酸的关键步骤。
Org Lett. 2004 Sep 16;6(19):3233-5. doi: 10.1021/ol0489806.
5
Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.用于高通量筛选细菌β-内酰胺酶对β-内酰胺抗生素抗性的荧光素标记β-内酰胺酶突变体
Anal Chem. 2005 Aug 15;77(16):5268-76. doi: 10.1021/ac0502605.
6
Cyclobutanone Analogues of β-Lactam Antibiotics: β-Lactamase Inhibitors with Untapped Potential?β-内酰胺抗生素的环丁酮类似物:具有未开发潜力的β-内酰胺酶抑制剂?
Chembiochem. 2017 Feb 16;18(4):338-351. doi: 10.1002/cbic.201600529. Epub 2017 Feb 7.
7
Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding.金属β-内酰胺酶抑制剂的生物等排替换:制备、活性和结合。
Eur J Med Chem. 2017 Jul 28;135:159-173. doi: 10.1016/j.ejmech.2017.04.035. Epub 2017 Apr 14.
8
Beta-lactamases and beta-lactamase inhibitors.β-内酰胺酶与β-内酰胺酶抑制剂
Int J Antimicrob Agents. 1999 Aug;12 Suppl 1:S3-7; discussion S26-7. doi: 10.1016/s0924-8579(99)00085-0.
9
Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.β-内酰胺类与β-内酰胺酶抑制剂联合制剂:抗菌活性及酶抑制效果
Am J Health Syst Pharm. 1995 Mar 15;52(6 Suppl 2):S15-22. doi: 10.1093/ajhp/52.6_Suppl_2.S15.
10
The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.修饰的青霉素和头孢菌素衍生的β-内酰胺酶抑制剂的发现与开发。
Curr Med Chem. 2004 Jul;11(14):1951-64. doi: 10.2174/0929867043364847.

引用本文的文献

1
Fabrication and characterization of a novel catalyst based on modified zirconium metal-organic-framework for synthesis of polyhydroquinolines.基于改性锆基金属有机骨架的新型催化剂的制备及其用于合成多氢喹啉的表征
Sci Rep. 2023 Oct 3;13(1):16584. doi: 10.1038/s41598-023-43869-2.
2
An effective antimicrobial complex of nanoscale β-cyclodextrin and ciprofloxacin conjugated to a cell adhesive dipeptide.一种由纳米级β-环糊精与环丙沙星共轭结合到一种细胞黏附二肽上形成的有效抗菌复合物。
RSC Adv. 2022 Dec 15;12(54):35383-35395. doi: 10.1039/d2ra05822g. eCollection 2022 Dec 6.
3
Nanoscale bioconjugates: A review of the structural attributes of drug-loaded nanocarrier conjugates for selective cancer therapy.
纳米级生物偶联物:用于选择性癌症治疗的载药纳米载体偶联物的结构属性综述。
Heliyon. 2022 Jun 2;8(6):e09577. doi: 10.1016/j.heliyon.2022.e09577. eCollection 2022 Jun.
4
High-performance sono/nano-catalytic system: CTSN/FeO-Cu nanocomposite, a promising heterogeneous catalyst for the synthesis of -arylimidazoles.高性能超声/纳米催化体系:CTSN/FeO-Cu纳米复合材料,一种用于合成芳基咪唑的有前景的多相催化剂。
RSC Adv. 2019 Dec 5;9(69):40348-40356. doi: 10.1039/c9ra08062g. eCollection 2019 Dec 3.
5
Enhanced antimicrobial treatment by a clay-based drug nanocarrier conjugated to a guanidine-rich cell penetrating peptide.通过与富含胍的细胞穿透肽偶联的粘土基药物纳米载体增强抗菌治疗。
RSC Adv. 2021 Dec 6;11(62):38961-38976. doi: 10.1039/d1ra07821f.